Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis

Documenti analoghi

• Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  di: Salaheldin Ahmed, et al.
  Pubblicazione: (2024)
• Risk Assessment Models and Event‐Free Survival in Pulmonary Arterial Hypertension
  di: Clara Hjalmarsson, et al.
  Pubblicazione: (2025)
• Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?
  di: Ambalavanan Arunachalam, et al.
  Pubblicazione: (2025)
• Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
  di: Marshaleen Henriques King, et al.
  Pubblicazione: (2025)
• Prognostic Role of Platelets in Pulmonary Arterial Hypertension
  di: Caio Julio Cesar dos Santos Fernandes, et al.
  Pubblicazione: (2025)